Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3.
Oncogene. 2015 Apr 16;34(16):2032-42. doi: 10.1038/onc.2014.146. Epub 2014 Jun 9.
Oncogene. 2015.
PMID: 24909168
Free PMC article.
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.
Zakaria C, Sean P, Hoang HD, Leroux LP, Watson M, Workenhe ST, Hearnden J, Pearl D, Truong VT, Robichaud N, Yanagiya A, Tahmasebi S, Jafarnejad SM, Jia JJ, Pelin A, Diallo JS, Le Boeuf F, Bell JC, Mossman KL, Graber TE, Jaramillo M, Sonenberg N, Alain T.
Zakaria C, et al. Among authors: hearnden j.
PLoS Pathog. 2018 Aug 23;14(8):e1007264. doi: 10.1371/journal.ppat.1007264. eCollection 2018 Aug.
PLoS Pathog. 2018.
PMID: 30138450
Free PMC article.
Item in Clipboard
La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1).
Fonseca BD, Zakaria C, Jia JJ, Graber TE, Svitkin Y, Tahmasebi S, Healy D, Hoang HD, Jensen JM, Diao IT, Lussier A, Dajadian C, Padmanabhan N, Wang W, Matta-Camacho E, Hearnden J, Smith EM, Tsukumo Y, Yanagiya A, Morita M, Petroulakis E, González JL, Hernández G, Alain T, Damgaard CK.
Fonseca BD, et al. Among authors: hearnden j.
J Biol Chem. 2015 Jun 26;290(26):15996-6020. doi: 10.1074/jbc.M114.621730. Epub 2015 May 4.
J Biol Chem. 2015.
PMID: 25940091
Free PMC article.
Item in Clipboard
mTORC1 promotes TOP mRNA translation through site-specific phosphorylation of LARP1.
Jia JJ, Lahr RM, Solgaard MT, Moraes BJ, Pointet R, Yang AD, Celucci G, Graber TE, Hoang HD, Niklaus MR, Pena IA, Hollensen AK, Smith EM, Chaker-Margot M, Anton L, Dajadian C, Livingstone M, Hearnden J, Wang XD, Yu Y, Maier T, Damgaard CK, Berman AJ, Alain T, Fonseca BD.
Jia JJ, et al. Among authors: hearnden j.
Nucleic Acids Res. 2021 Apr 6;49(6):3461-3489. doi: 10.1093/nar/gkaa1239.
Nucleic Acids Res. 2021.
PMID: 33398329
Free PMC article.
Item in Clipboard
Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States.
Tremblay G, Said Q, Roy AN, Cai B, Ashton Garib S, Hearnden J, Forsythe A.
Tremblay G, et al. Among authors: hearnden j.
Clinicoecon Outcomes Res. 2019 Nov 12;11:673-681. doi: 10.2147/CEOR.S226323. eCollection 2019.
Clinicoecon Outcomes Res. 2019.
PMID: 31814747
Free PMC article.
Item in Clipboard
Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2- advanced breast cancer.
Tremblay G, Chandiwana D, Dolph M, Hearnden J, Forsythe A, Monaco M.
Tremblay G, et al. Among authors: hearnden j.
Cancer Manag Res. 2018 May 22;10:1319-1327. doi: 10.2147/CMAR.S163478. eCollection 2018.
Cancer Manag Res. 2018.
PMID: 29861642
Free PMC article.
Item in Clipboard
A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists.
Dolph M, Roy A, Bhor M, Hearnden J, Kwon CS, Forsythe A, Tremblay G, Briggs A.
Dolph M, et al. Among authors: hearnden j.
J Comp Eff Res. 2018 Aug;7(8):775-784. doi: 10.2217/cer-2018-0034. Epub 2018 May 31.
J Comp Eff Res. 2018.
PMID: 29848048
Free article.
Item in Clipboard
Cite
Cite